Skip to main content
Erschienen in:

01.12.2024 | PFLEGE & WISSENSCHAFT

Cochrane Pflege Forum

Lösungen zum Blocken von Dialysekathetern

verfasst von: Martin Fangmeyer, BScN, MScN, Peter Redl-Lenk

Erschienen in: PRO CARE | Ausgabe 10/2024

Einloggen, um Zugang zu erhalten

Auszug

Literatur
2.
Zurück zum Zitat Almeida, B.M., et al., Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis. Cochrane Database Syst Rev, 2022. 4(4): p. Cd013554. Almeida, B.M., et al., Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis. Cochrane Database Syst Rev, 2022. 4(4): p. Cd013554.
3.
Zurück zum Zitat Arechabala, M.C., et al., Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis. Cochrane Database of Systematic Reviews, 2018. 4: p. CD010597. Arechabala, M.C., et al., Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis. Cochrane Database of Systematic Reviews, 2018. 4: p. CD010597.
5.
Zurück zum Zitat Vandenbosch, I., et al., Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study. Clinical Kidney Journal, 2021. 14(8): p. 1901–1907. Vandenbosch, I., et al., Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study. Clinical Kidney Journal, 2021. 14(8): p. 1901–1907.
6.
Zurück zum Zitat Solomon, L.R., et al., A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. American Journal of Kidney Diseases, 2010. 55(6): p. 1060–8. Solomon, L.R., et al., A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. American Journal of Kidney Diseases, 2010. 55(6): p. 1060–8.
7.
Zurück zum Zitat Winnicki, W., et al., Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney International, 2018. 93(3): p. 753–760. Winnicki, W., et al., Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters. Kidney International, 2018. 93(3): p. 753–760.
8.
Zurück zum Zitat Elahi, R., et al., The Efficacy of Taurolidine Citrate Solution versus Heparin Lock Solution Instilled in the Catheter Lumens of End Stage Renal Disease Patients on Hemodialysis. Pakistan journal of medical and health sciences, 2022. 16(9): p. 152–154. Elahi, R., et al., The Efficacy of Taurolidine Citrate Solution versus Heparin Lock Solution Instilled in the Catheter Lumens of End Stage Renal Disease Patients on Hemodialysis. Pakistan journal of medical and health sciences, 2022. 16(9): p. 152–154.
Metadaten
Titel
Cochrane Pflege Forum
Lösungen zum Blocken von Dialysekathetern
verfasst von
Martin Fangmeyer, BScN, MScN
Peter Redl-Lenk
Publikationsdatum
01.12.2024
Verlag
Springer Vienna
Erschienen in
PRO CARE / Ausgabe 10/2024
Print ISSN: 0949-7323
Elektronische ISSN: 1613-7574
DOI
https://doi.org/10.1007/s00735-024-1918-y